Abstract
Abstract. In recent years, numerous countries around the world have continually devoted substantial efforts to the biotechnology industry. Despite its endeavors over two decades, Taiwan’s biotechnology industry has not yet made any remarkable achievements. In this study, influential factors of cooperation in the biotechnology industry are discussed from the perspectives of cluster cooperation and interaction. Using the analytic hierarchy process and quantitative results obtained from in-depth expert interview questionnaires, the weights of various influential factors are investigated and analyzed, which could provide a reference for future research and resource allocations. The influential factors of cluster cooperation in Taiwan’s biotechnology industry can be categorized into four major factors and sixteen sub-factors. The results indicate that among all of the factors that impact cluster cooperation in the biotechnology industry, “enterprise innovation ability” is the most critical. The innovation capacity of cooperative partners is always considered a priority in cluster cooperation among enterprises, whereas research and development (R&D), personnel quality, and the R&D environment are the most crucial sub-factors within the primary dimension of enterprise innovation ability. This finding is consistent with the fact that a biotechnology product is closely bound to innovative R&D, from its initial development stage to the eventual clinical launch. Factors of secondary importance include business management ability and government resource utilization, which suggests that the principal activities associated with cluster cooperation in the biotechnology industry depend heavily on an enterprise’s business management ability and are inextricably linked to government resource utilization.
Keywords. Biotechnology industry, Cluster cooperation, Taiwan, Analytic hierarchy process (AHP).
JEL. C22, O40, O43.
References
Bien, H.J., Ben, T.M., & Wang, K.F. (2014). Trust relationship within R&D networks: A case study from the biotechnology industry. Innovation Management, Policy & Practice, 16(3), 354-373. doi. 10.1080/14479338.2016.1187574
Cooke, P., Uranga, M.G., & Etxebarria, G. (1997). Regional innovation systems: Institutional and organizational dimensions. Researh Policy, 26(4-5), 475–491. doi. 10.1016/S0048-7333(97)00025-5
Downs, J.B. & Velamuri, V.K. (2016). Business model innovation opportunities for the biopharmaceutical industry: A systematic review. Journal of Commercial Biotechnology, 22(3), 19–63. doi. 10.5912/jcb735
Drejer, I., & Jorgensen, B.H., (2005). The dynamic creation of knowledge: Analysing public private collaborations. Technovation, 25(9), 83-94. doi. 10.1016/S0166-4972(03)00075-0
Edquist, C. (2005). Systems of innovation-perspectives and challenges, in, J. Fagerberg, D. Mowery & R. Nelson (Eds).The Oxford Handbook of innovation, (pp.181-208). Oxford: Oxord University Press.
Ernst & Young, (2016), Beyond Borders Returning to Earth, London: Ernst and Young.
Feldman, M.P. & Francis, J.L. (2003). Fortune favours the prepared region: The case of entrepreneurship and the capitol region biotechnology cluster. European Planning Studies, 11(7), 765–788. doi. 10.1080/0965431032000121337
Hsu, W.L., Shen Y.C., Yuan J.C., & Chou C.Y. (2015). Toward successful commercialization of university technology: Performance drivers of university technology transfer in Taiwan. Technological Forecasting & Social Change, 92, 25–39. doi. 10.1016/j.techfore.2014.11.002
Hu, M.C., & Hung, S.C. (2014). Taiwan's pharmaceuticals: A failure of the sectoral system of innovation?. Technological Forecasting & Social Change, 88, 162–176. doi. 10.1016/j.techfore.2014.06.021
Huang, Y.C., & Wu, Y.C. (2010). Intellectual capital and knowledge productivity: the Taiwan biotech industry. Management Decision, 48(4), 580-599. doi. 10.1108/00251741011041364
Montalvo, F. (2011). Economic growth and innovation: Lessons in knowledge sharing from bioscience clusters in Ohio and Puerto Rico. Global Business and Organizational Excellence, 31(1), 54-62. doi. 10.1002/joe.21404
Okamuro, H., & Nishimura, J. (2015). Local management of national cluster policies: Comparative case studies of Japanese, German, and French biotechnology clusters. Administrative Sciences, 5(4), 213–239. doi. 10.3390/admsci5040213
Rosson, P., & McLarney, C. (2005). Developing clusters in peripheral regions: Biotechnology in Halifax, Nova Scotia, Canada. Paper presented at the 8th Uddevalla Symposium, Uddevalla, 15-17 September.
Saaty, T.L. (1980). The Analytic Hierarchy Process, New York: McGraw- Hill.
Su, Y.-S., &Hung, L.-C., (2009). Spontaneous vs. policy-driven: the origin and evolution of the biotechnology cluster. Technological Forecasting Social Change 76(5), 608–619. doi. 10.1016/j.techfore.2008.08.008
Subramaniam, M., & Youndt, M.A. (2005). The influence of intellectual capital on the types of innovative capabilities. Academy of Management Journal, 48(3), 450-63. doi. 10.5465/AMJ.2005.17407911
Talavyria, M.P., Lymar, V.V., & Baidala, V.V., (2015). Improvement of the bioeconomy development analysis instruments: European Union Projects and Germany experience. Економіка АПК, 11, 89-95.
Todtling, F., & Lehner, M. (2006). Innovation in knowledge intensive industries: the nature and geography of knowledge links. European Planning Studies, 14(8),1035-1058. doi. 10.1080/09654310600852365
Trippl, M., & Tödtling, F. (2007). Developing biotechnology clusters in non‐high technology regions -The case of Austria. Industry and Innovation, 14(1), 47-67. doi. 10.1080/13662710601130590
